Guardian Pharmacy Services, Inc. (GRDN)

Guardian Pharmacy Services topped consensus on both revenue and adjusted EPS in the second fiscal quarter of 2026, with preliminary results reported on 2026-08-06: adjusted EPS of $0.29 beat the $0.26 estimate by 10.8%, while revenue of about $351.8 million exceeded the roughly $340.4 million consensus by 3.3%. Revenue rose 2.2% from about $344.3 million a year ago, and at the operating line the business posted about $20.6 million of income as operating margin held around 5.9%. Gross margin near 22.8% framed the quarter’s profit profile. Net income was about $21.9 million, up 142.2% from about $9.0 million a year earlier, while adjusted EPS increased 26.1% from $0.23. The company generated operating cash flow of about $36.1 million and repurchased about $30.3 million of stock, leaving cash generation alongside capital return as part of the quarter’s read-through.